Organisation
Basic (bio-) Medical Sciences
Department
Basic and applied biomedical research, and biomedical science-based higher education.
Current researchers
61 - 70 of 155 results
- Dirk Hose (Member)
- I Houbracken (Member)
- Anfien Huyghebaert (Member)
- Daniel Jacobs-Tulleneers-Thevissen (Member)
- Charlotte Janssens (Member)
- Mathias Janssens (Member)
- Hendrika Jaspers (Member)
- Shanthini Kannan (Member)
- Mina Kazemzadeh Dastjerd (Member)
- Elisabeth Knetemann (Member)
Projects
61 - 70 of 140
- Assessing the risk of SARS-CoV-2 infection for pregnancy and as possible cause of birth defectsFrom1 Nov 2020 → 31 Oct 2021Funding: FWO Special Call for Covid-19 research projects
- The impact of recurrent chromosomal abnormalities on growth advantage and differentiation capacity of human pluripotent stem cellsFrom1 Nov 2020 → TodayFunding: FWO fellowships
- Creation of a dynamic intercellular liver communication platform to establish an anti-fibrotic combo-therapy for chronic liver diseases.From1 Nov 2020 → 31 Oct 2023Funding: FWO fellowships
- SBO project with a primary economic finality aimed at the transfer to existing companies : iPSC-based parenchymal and sinusoidal liver cell mimics for DILI and NAFLD studies (iPSC-LiMic)From1 Oct 2020 → TodayFunding: FWO Strategic Basic Research (SBO)
- Development of innovative NANObody-based therapies to eradicate REsidual disease in Multiple Myeloma (acronym: NANOREMM)From1 Oct 2020 → 31 Dec 2023Funding: FWO fellowships
- Seahorse platform: the Agilent Seahorse Flux Analyser with integrated normalization systemFrom1 May 2020 → TodayFunding: Hercules - Small and Medium size research infrastructure
- Horizon 2020: I-MOVE-COVID-19 : Multidisciplinary European network for research, prevention and control of the COVID-19 PandemicFrom16 Mar 2020 → 15 Jun 2022Funding: H2020-EU.3.1. - SOCIETAL CHALLENGES - Health, demographic change and wellbeing
- GEAR: Brussels Liver Research to Valorisation Alliance (B-Liver): Valorisation of VUB’s liver cell biology and toxicology expertise via a consortium focused on liver therapeutics, patient and consumer safety.From1 Jan 2020 → TodayFunding: IOF - technology concept exploration, IOF - mandates
- GEAR: Integrating a multimodal approach to address current challenges in immunotherapy (INTEGRAL)From1 Jan 2020 → TodayFunding: IOF - technology validation in real environment, IOF - mandates
- Sinusoidal cell communication in liver fibrosisFrom1 Jan 2020 → 31 Dec 2020Funding: FWO research grant KAN
Publications
1 - 10 of 1116
- Detection of vertebral fractures in CT using 3D Convolutional Neural Networks(2020)
Authors: Joeri Nicolaes, Steven Raeymaeckers, David Robben, Guido Wilms, Dirk Vandermeulen, Cesar Libanati, Marc DeBois
Pages: 3-14 - T cell-based targeted immunotherapies for patients with multiple myeloma
Authors: Lei Wang, Nan Jin, Anita Schmitt, Jochen Greiner, Georg Malcherek, Michael Hundemer, Jiju Mani, Dirk Hose, Marc S Raab, Anthony D Ho, et al.
Pages: 1751-1768 - Antigen-mediated regulation in monoclonal gammopathies and myeloma
Authors: Shiny Nair, Joel Sng, Chandra Sekhar Boddupalli, Anja Seckinger, Marta Chesi, Mariateresa Fulciniti, Lin Zhang, Navin Rauniyar, Michael Lopez, Natalia Neparidze, et al.
- High cereblon expression is associated with better survival in patients with newly diagnosed multiple myeloma treated with thalidomide maintenance
Authors: Annemiek Broyl, Rowan Kuiper, Mark van Duin, Bronno van der Holt, Laila el Jarari, Uta Bertsch, Sonja Zweegman, Arjan Buijs, Dirk Hose, Henk M. Lokhorst, et al.
Pages: 624-627 - Cytogenetic subclone formation and evolution in progressive smoldering multiple myeloma
Authors: Maximilian Merz, Thomas Hielscher, David Schult, Elias K Mai, Marc S Raab, Jens Hillengass, Anja Seckinger, Dirk Hose, Martin Granzow, Anna Jauch, et al.
Pages: 1192-1196 - Sorafenib in patients with refractory or recurrent multiple myeloma
Authors: Anna Yordanova, Dirk Hose, Kai Neben, Mathias Witzens-Harig, Ines Gütgemann, Marc-Steffen Raab, Thomas M Moehler, Hartmut Goldschmidt, Ingo G H Schmidt-Wolf
Pages: 197-200 - The glycome of normal and malignant plasma cells
Authors: Thomas M Moehler, Anja Seckinger, Dirk Hose, Mindaugas Andrulis, Jèrôme Moreaux, Thomas Hielscher, Martina Willhauck-Fleckenstein, Anette Merling, Uta Bertsch, Anna Jauch, et al.
- Upregulation of FOXM1 in a subset of relapsed myeloma results in poor outcome
Authors: Chunyan Gu, Carol Holman, Ramakrishna Sompallae, Xuefang Jing, Michael Tomasson, Dirk Hose, Anja Seckinger, Fenghuang Zhan, Guido Tricot, Hartmut Goldschmidt, et al.
- Inherited genetic susceptibility to monoclonal gammopathy of unknown significance
Authors: Niels Weinhold, David C Johnson, Andrew C Rawstron, Asta Försti, Chi Doughty, Jayaram Vijayakrishnan, Peter Broderick, Nasrin B Dahir, Dil B Begum, Fay J Hosking, et al.
Pages: 2513-2517 - A gene expression based predictor for high risk myeloma treated with intensive therapy and autologous stem cell rescue
Authors: Xiao-Ping Wu, Brian A Walker, Annemiek Broyl, Martin Kaiser, David C Johnson, Rowan Kuiper, Mark van Duin, Walter M Gregory, Faith E Davies, Daniel Brewer, et al.
Pages: 594-601